Atria Wealth Solutions Inc. Has $304,000 Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Atria Wealth Solutions Inc. trimmed its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 10.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,524 shares of the company’s stock after selling 416 shares during the period. Atria Wealth Solutions Inc. owned about 0.06% of VanEck Pharmaceutical ETF worth $304,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Blue Chip Partners LLC acquired a new stake in VanEck Pharmaceutical ETF in the 4th quarter valued at $2,139,000. NTV Asset Management LLC increased its stake in VanEck Pharmaceutical ETF by 3.6% in the 4th quarter. NTV Asset Management LLC now owns 7,709 shares of the company’s stock valued at $665,000 after buying an additional 271 shares during the last quarter. Activest Wealth Management acquired a new stake in VanEck Pharmaceutical ETF in the 4th quarter valued at $32,000. Apollon Wealth Management LLC increased its stake in VanEck Pharmaceutical ETF by 14.2% in the 4th quarter. Apollon Wealth Management LLC now owns 32,708 shares of the company’s stock valued at $2,822,000 after buying an additional 4,076 shares during the last quarter. Finally, IMC Chicago LLC acquired a new stake in VanEck Pharmaceutical ETF in the 4th quarter valued at $896,000.

VanEck Pharmaceutical ETF Trading Up 1.3 %

Shares of PPH stock opened at $93.65 on Friday. VanEck Pharmaceutical ETF has a 1 year low of $84.48 and a 1 year high of $99.51. The firm’s fifty day moving average price is $88.16 and its two-hundred day moving average price is $91.47. The firm has a market capitalization of $584.38 million, a P/E ratio of 21.04 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently declared a dividend, which was paid on Monday, December 30th. Shareholders of record on Friday, December 27th were paid a $0.411 dividend. This is a positive change from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date of this dividend was Friday, December 27th.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.